Prot #EDGE-Lung: A Phase II, Open-Label, Platform Study, to Evaluate Immunotherapy-Based Combinations in Participants With Advanced Non-Small Cell Lung Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date2/14/24 → 2/14/27

Funding

  • ICON Clinical Research Limited (Prot #EDGE-Lung // Prot #EDGE-Lung)
  • Gilead Sciences, Inc (Prot #EDGE-Lung // Prot #EDGE-Lung)